-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Arvinas, Raises Price Target to $18

Benzinga·12/17/2025 17:34:40
Listen to the news
Barclays analyst Etzer Darout maintains Arvinas (NASDAQ:ARVN) with a Overweight and raises the price target from $16 to $18.